Cat. No. 5667
Chemical Name: B-[2-Methoxy-5-[(1E)-3-oxo-3-(3,4,5
Biological ActivitySIRT1 activator. Inhibits proliferation of breast cancer cell lines expressing mutant p53. Induces G2/M cell cycle arrest and apoptosis in triple negative breast cancer cells (TNBCs) in vitro.
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
All Tocris products are intended for laboratory research use only.
Certificate of Analysis / Product Datasheet / Safety Datasheet
References are publications that support the products' biological activity.
Ponnusamy et al (2015) Activation of sirtuin-1 promotes renal fibroblast activation and aggravates renal fibrogenesis. J.Pharmacol.Exp.Ther 354 142. PMID: 26022003.
Yi et al (2013) Targeting mutant p53 by a SIRT1 activator YK-3-237 inhibits the proliferation of triple-negative breast cancer cells. Oncotarget 4 984. PMID: 23846322.
If you know of a relevant reference for YK 3-237 please let us know.
Citations are publications that use Tocris products.
Do you know of a great paper that uses YK 3-237 from Tocris? If so please let us know.
View Related Products by Product Action
Keywords: YK 3-237, supplier, YK3-237, SIRT1, sirtuins, activators, activates, deacetylases, antiproliferative, Tocris Bioscience, Sir 2-like Family Deacetylase Activator products
Find multiple products by catalog number
July 8 - 12, 2017